MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Utility of Instrumented Timed Up and Go Test to Estimate Disease Severity in Huntington Disease.

    D. Wani, M. Lin, C. Macpherson, T. Ravikumar, M. Campbell, L. Muratori, N. Fritz, L. Quinn (New York, USA)

    Objective: To investigate the utility of Instrumented Timed Up and Go (TUG) test to estimate disease severity in people with Huntington Disease (PwHD). Background: Huntington…
  • 2024 International Congress

    Touchscreen performance in people with Parkinson’s Disease

    N. Cohen, R. Kizony (Haifa, Israel)

    Objective: To investigate touchscreen performance and its associations with cognitive ability and upper limb (UL) function in people with Parkinson’s Disease (PWP). Background: Touchscreen use…
  • 2024 International Congress

    PD in Tanzania: representative in city dwellers, absent in nomadic tribespeople?

    S. Urasa, W. Howlett, R. Walker, M. Dekker (Moshi, United Republic of Tanzania)

    Objective: To investigate the aetiology of PD demographically in an under researched region. Background: PD monogenic and susceptibility risk factors explain little to none of…
  • 2024 International Congress

    Monitoring Progress: Use of the Behavioral Dyscontrol Scale-2 (BDS-2) in FXTAS (Fragile X-associated Tremor Ataxia Syndrome) Progression

    H. Hasan, A. Mokhtabad Amrei, E. Santos, H. Biag, A. Schneider, J. Wang, R. Hagerman (Sacramento, USA)

    Objective: To investigate the use of  the neuropsychological BDS-2 measures and its correlation with MRI findings and FXTAS stages[1] Background: Fragile X-associated Tremor Ataxia Syndrome…
  • 2024 International Congress

    Prevalence of Helicobacter Pylori Infection Among Nepalese Parkinson’s Disease Patients and their Clinical Manifestations

    R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, R. Hamal, A. Jha, R. Pathak (Kathmandu, Nepal)

    Objective: To know the prevalence of Helicobacter Pylori infection among Nepalese Parkinson´s Disease patients and understand their clinical characteristics Background: Helicobacter pylori (HP) is prevalent…
  • 2024 International Congress

    Unveiling Parkinson’s Disease Risk Factors in the European Population-Based HeBA Cohort

    A. Garrido, C. Horlings, K. Rege, S. Schade, S. Ghosh, P. Mahlknecht, R. Rawal, T. Marques, D. Pilco, C. Gomes, C. Pauly, F. Farfan, D. Mcintyre, K. Seppi, MJ. Marti, C. Trenkwalder, W. Poewe, E. Tolosa, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

    Objective: Describe the frequency of Parkinson’s disease (PD) risk factors in a European population-based study and analyze the predictive value of online survey single questions…
  • 2024 International Congress

    Prodromal RBD and the risk of cognitive impairment in Parkinson’s disease.

    A. Martinez-Nunez, H. Hutchinson, V. Lavu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesvile, USA)

    Objective: To identify the impact of prodromal RBD in the incidence of cognitive impairment in patients with early PD. Background: The association between sleep disorders…
  • 2024 International Congress

    Movement Disorder Society Unified Parkinson’s Disease Rating Scale Motor Examination Retains Its 2-Domain Profile in Both On and Off States

    T. Mestre, G. Stebbins, C. Goetz, S. Luo (Ottawa, Canada)

    Objective: This study aims to validate the two-domain structure of MDS-UPDRS Part III items in both medication states, exploring the discriminative ability of the tremor…
  • 2024 International Congress

    Comorbidity of schizophrenia and Parkinson’s disease: a clinical case report

    M. Khommyatov, M. Samushiya, I. Smolentseva, S. Kryzhanovskiy (Moscow, Russian Federation)

    Objective: To describe the case of a patient with paranoid schizophrenia followed by the onset of the Parkinson’s disease at the 44-year age Background: Currently…
  • 2024 International Congress

    Suicide risk relationship with motor and non-motor symptoms in patients with Parkinson’s disease.

    I. Estrada-Bellmann, A. Ontiveros -Sanchez, R. Trejo-Ayala, G. Porras-Garza, L. Dela Garza, G. Sanchez-Torres, R. Ruiz-Meza, P. Cortes-Estrada (MONTERREY, Mexico)

    Objective: Determine Suicide Risk relationship with motor and non motor symptoms in patients with Parkinson´s disease. Background:  Suicidal ideation is increased in people with Parkinson's…
  • « Previous Page
  • 1
  • …
  • 232
  • 233
  • 234
  • 235
  • 236
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley